HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioblastoma Multiforme · Astrocytoma, Grade III

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Houston Methodist Neurological Institute, Houston, Texas, United States
Contact: Study coordinator (David S Baskin, MD) · DBaskin@houstonmethodist.org · 713-441-3800
Contact: Study coordinator (Helga M Jones) · HMJones@houstonmethodist.org · 713-363-9388

Study leads

David S Baskin, MD
Principal Investigator
Houston Methodist Neurological Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Glioblastoma · Anaplastic Astrocytoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Malignant Glioma of Brain · Astrocytoma · Malignant Astrocytoma

Abroad (travel likely)RecruitingPHASE1

Detroit, United States

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

St Louis, United States